PEG-rhG-CSF: Clinical Trials

5 trials of PEG-rhG-CSF, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed, 1 unknown. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Recruiting 3, Completed 1, Unknown 1
Phase 21Completed 1

Follow PEG-rhG-CSF: new trials by email Literature Review of PEG-rhG-CSF trials Research Report on PEG-rhG-CSF

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Etoposide, Cytarabine, PEG-rhG-CSF - Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization
Phase 3RecruitingThe Affiliated People's Hospital of Ningbo University992024-08-012025-12-04
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Etoposide, Cytarabine, Pegfilgrastim - Multiple Myeloma, Hematopoietic Stem Cell Mobilization
Phase 3RecruitingThe Affiliated People's Hospital of Ningbo University992024-08-012024-07-25
Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF
MW05, PEG-rhG-CSF - Breast Cancer Female
Phase 2 / Phase 3CompletedMabwell (Shanghai) Bioscience Co., Ltd.5862020-09-212022-12-02
Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
Involved field irradiation, Elective field irradiation, Paclitaxel - Esophageal Cancer
Phase 3RecruitingChinese Academy of Medical Sciences3002018-11-012018-12-12
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
PEG-rhG-CSF - Breast Cancer
Phase 3Unknownwang shusen3382016-05-042017-06-01

Conditions studied

Breast Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Recurrence (1)

Sponsors

The Affiliated People's Hospital of Ningbo University (2)  ·  Chinese Academy of Medical Sciences (1)  ·  Mabwell (Shanghai) Bioscience Co., Ltd. (1)  ·  wang shusen (1)

Countries

China (5)

Top investigators

Peipei Ye (1)  ·  Shusen Wang, Doctor (1)  ·  Ying Lu (1)

Results publications

PMID 32928136